Search results
Results from the WOW.Com Content Network
Cyclotron beams can be used to bombard other atoms to produce short-lived isotopes with a variety of medical uses, including medical imaging and radiotherapy. [62] Positron and gamma emitting isotopes, such as fluorine-18 , carbon-11 , and technetium-99m [ 63 ] are used for PET and SPECT imaging.
Fixed-field machines, such as cyclotrons and FFAs, use the former approach and allow the particle path to change with acceleration. In order to keep particles confined to a beam, some type of focusing is required. Small variations in the shape of the magnetic field, while maintaining the same overall field direction, are known as weak focusing.
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off. It employs about 1500 people in 40 locations. [1]
Used to separate Uranium 235 isotope for the Manhattan project, after the end of World War II used for separation of medical and other isotopes. 95-inch cyclotron Harvard Cyclotron Laboratory: 1949–2002 Circular Proton 160 MeV Used for nuclear physics 1949 – ~ 1961, development of clinical proton therapy until 2002 JULIC
Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington.
The feasibility of 99m Tc production with the 22-MeV-proton bombardment of a 100 Mo target in medical cyclotrons was demonstrated in 1971. [48] The recent shortages of 99m Tc reignited the interest in the production of "instant" 99mTc by proton bombardment of isotopically enriched 100 Mo targets (>99.5%) following the reaction 100 Mo(p,2n) 99m ...
The control panel of the Harvard Cyclotron Laboratory circa 1950. The Harvard Cyclotron Laboratory operated from 1949 to 2002. It was most notable for its contributions to the development of proton therapy.
Fourier-transform ion cyclotron resonance (FTICR) mass spectrometry is a high-resolution technique that can be used to determine masses with high accuracy. Many applications of FTICR-MS use this mass accuracy to help determine the composition of molecules based on accurate mass. This is possible due to the mass defect of the elements.